findmyKOL
Clinical trialNCT03322566CompletedPhase 2Interventional

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

SponsorIncyte CorporationEnrollment233Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Blacktown Hospital

    Blacktown, New South Wales, Australia

  • Chris Obrien Lifehouse

    Camperdown, New South Wales, Australia

  • the Crown Princess Mary Cancer Centre Westmead

    Westmead, New South Wales, Australia

  • Southern Medical Day Care Centre

    Wollongong, New South Wales, Australia

  • Mncci Port Macquarie Base Hospital

    Port Macquarie, New South Wales (Australia), Australia

  • Cairns Base Hospital

    Cairns, Queensland, Australia

Canada
  • Bcca-Cancer Centre of the Southern Interior

    Kelowna, British Columbia, Canada

  • Lions Gate Hospital

    North Vancouver, British Columbia, Canada

  • Cisss de la Monteregie-Centre

    Greenfield Park, Quebec, Canada

  • Csss de Laval- Hopital de la Cite de la Sante

    Laval, Quebec, Canada

  • Ciusss Ouest de L'Ile - St-Mary'S Hospital

    Montreal, Quebec, Canada

  • Ciusss Du Nord-de-L'Ile-de-Montreal Hopital Du Sacre-Coeur de Montreal

    Montreal, Quebec, Canada

  • Chu de Quebec - Hotel-Dieu de Quebec

    Québec, Quebec, Canada

  • Ciusss de la Mauricie-Et-Du-Centre-Du-Quebec

    Trois-Rivières, Quebec, Canada

Hungary
  • Zala Megyei Korhaz Pozvai Telephely

    Pózva, Zalaegerszeg, Hungary

  • Orszagos Koranyi Tbc Es Pulmonologiai Intezet

    Budapest, Hungary

  • Veszprem Megyei Tudogyogyintezet

    Farkasgyepű, Hungary

  • Bekes Megyei Pandy Kalman Korhaz

    Gyula, Hungary

  • Cru Hungary Kft.

    Miskolc, Hungary

  • Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet

    Szolnok, Hungary

Ireland
  • St Vincents University Hospital

    Dublin, Ireland

Israel
  • Ha Emek Medical Center

    Afula, Israel

  • Soroka Medical Center

    Beersheba, Israel

  • Rambam Medical Center

    Haifa, Israel

  • Meir Medical Center

    Kfar Saba, Israel

  • Rabin Medical Center

    Petah Tikva, Israel

  • Chaim Sheba Medcal Center

    Ramat Gan, Israel

Italy
  • Centro Di Riferimento Oncologico

    Aviano, Italy

  • A.O.U. Policlinico Vittorio Emanuele - Presidio Gaspare Rodolico

    Catania, Italy

  • Fondazione Irccs Istituto Nazionale Dei Tumori

    Milan, Italy

  • Istituto Europeo Di Oncologia

    Milan, Italy

  • Ospedale San Gerardo - Asst Monza

    Monza, Italy

Mexico
  • Medical Care Research S.A. de C.V.

    Mérida, Yucatán, Mexico

  • Oaxaca Site Management Organization S.C.

    Oaxaca City, Mexico

  • Faicic Clinical Research

    Veracruz, Mexico

Russia
  • Belgorod Regional Oncology Dispensary

    Belgorod, Russia

  • Udmurtia Republic Regional Clinical Oncology Dispensary

    Izhevsk, Russia

  • Republican Clinical Oncology Dispensary of Tatarstan Moh

    Kazan', Russia

  • Central Clinical Hospital With Polyclinic

    Moscow, Russia

  • Moscow Research Oncology Institute

    Moscow, Russia

54 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Jan 2018
Primary completion
13 Dec 2018
Completion
16 Oct 2020
Last update posted
24 Jan 2022
Registered enrollment
233
Registry id
NCT03322566

Cross-registrations

EU-CTR / CTIS (EudraCT)2017-001810-27

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.